$1.86
At close: Apr 8 EDT
$1.81
-0.05-2.69%
Pre-Market: 7:48 PM EDT
Comments
Loading...
Sonoma Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:SNOA | Benzinga
Sonoma Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jun 16
EPS Estimate
$-0.600
Quarterly Revenue Estimate
$4.44M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$13.97M
Analyze the earnings history of Sonoma Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SNOA | Sonoma Pharmaceuticals | -$1.40 | -$0.60 | — | — | $3.44M | $4.44M | — | — | 06/16/2025 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$1.60 | -$0.60 | -$0.63 | -5.00% | $3.14M | $4.06M | $3.56M | -12.22% | 02/05/2025 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$5.80 | -$1.00 | -$0.59 | 41.00% | $2.73M | $3.98M | $3.58M | -10.08% | 11/07/2024 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$5.80 | -$1.20 | -$1.40 | -16.67% | $3.43M | $3.94M | $3.39M | -13.93% | 08/08/2024 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$6.20 | — | -$1.40 | — | $3.01M | $3.98M | $3.44M | -13.59% | 06/17/2024 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$12.40 | — | -$1.60 | — | $2.94M | — | $3.14M | — | 02/08/2024 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$6.60 | -$4.80 | -$5.80 | -20.83% | $3.33M | $3.48M | $2.73M | -21.52% | 11/13/2023 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$5.80 | — | -$5.80 | — | $3.98M | — | $3.43M | — | 08/10/2023 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$21.40 | — | -$6.20 | — | $2.30M | — | $3.01M | — | 06/22/2023 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$6.20 | — | -$12.40 | — | $2.90M | — | $2.94M | — | 02/14/2023 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$0.80 | — | -$6.60 | — | $3.74M | — | $3.33M | — | 11/14/2022 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$10.40 | — | -$5.80 | — | $3.68M | — | $3.98M | — | 08/11/2022 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$32.80 | — | -$21.40 | — | $2.16M | — | $2.30M | — | 07/13/2022 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$6.20 | — | -$6.20 | — | $4.94M | — | $2.90M | — | 02/11/2022 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | $1.60 | — | -$0.80 | — | $5.77M | — | $3.74M | — | 11/15/2021 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$7.60 | — | -$10.40 | — | $5.77M | — | $3.68M | — | 08/16/2021 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$15.40 | — | -$32.80 | — | $4.58M | — | $2.16M | — | 07/14/2021 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$14.40 | — | -$6.20 | — | $4.68M | — | $4.94M | — | 02/16/2021 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$18.20 | — | $1.60 | — | $4.97M | — | $5.77M | — | 11/20/2020 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | — | — | $0.40 | — | $4.71M | — | $7.25M | — | 08/14/2020 | Get Alert |
| SNOA | Sonoma Pharmaceuticals | -$49.00 | — | -$15.40 | — | $4.38M | — | $4.58M | — | 07/10/2020 | Get Alert |
Sonoma Pharmaceuticals (SNOA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-02-05 | $-0.63 | $-0.60 | -5.00 % |
| Q2 | 2024-11-07 | $-0.59 | $-1.00 | 41.0 % |
| Q1 | 2024-08-08 | $-1.40 | $-1.20 | -16.7 % |
| Q2 | 2023-11-13 | $-5.80 | $-4.80 | -20.8 % |
Sonoma Pharmaceuticals (SNOA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-02-05 | $3.56M | $4.06M | -12.2 % |
| Q2 | 2024-11-07 | $3.58M | $3.98M | -10.1 % |
| Q1 | 2024-08-08 | $3.39M | $3.94M | -13.9 % |
| Q4 | 2024-06-17 | $3.44M | $3.98M | -13.6 % |
FAQ
When is Sonoma Pharmaceuticals (NASDAQ:SNOA) reporting earnings?
Sonoma Pharmaceuticals (SNOA) is scheduled to report earnings on June 16, 2025. The last reported earnings were for reported on February 5, 2025 for Q3.
What were the latest earnings per share (EPS) for Sonoma Pharmaceuticals (NASDAQ:SNOA)?
The Actual EPS was $-0.63, which missed the estimate of $-0.60.
What were Sonoma Pharmaceuticals’s (NASDAQ:SNOA) revenues?
The Actual Revenue was $3.6M, which missed the estimate of $4.1M.
Browse earnings estimates, EPS, and revenue on all stocks.